Trade Ocugen, Inc. - OCGN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0184 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.6258 |
| Open | 1.6358 |
| 1-Year Change | 202.93% |
| Day's Range | 1.5758 - 1.6458 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 1.6158 | 0.0500 | 3.19% | 1.5658 | 1.6558 | 1.5658 |
| Jul 24, 2024 | 1.5958 | -0.0700 | -4.20% | 1.6658 | 1.6858 | 1.5758 |
| Jul 23, 2024 | 1.6858 | 0.0800 | 4.98% | 1.6058 | 1.7058 | 1.6058 |
| Jul 22, 2024 | 1.6258 | -0.0200 | -1.22% | 1.6458 | 1.6758 | 1.5958 |
| Jul 19, 2024 | 1.6558 | 0.0200 | 1.22% | 1.6358 | 1.7558 | 1.6158 |
| Jul 18, 2024 | 1.6258 | -0.1200 | -6.87% | 1.7458 | 1.7858 | 1.5758 |
| Jul 17, 2024 | 1.8258 | -0.0600 | -3.18% | 1.8858 | 1.9158 | 1.7958 |
| Jul 16, 2024 | 1.9358 | 0.0200 | 1.04% | 1.9158 | 1.9658 | 1.8858 |
| Jul 15, 2024 | 1.8958 | 0.0200 | 1.07% | 1.8758 | 1.9258 | 1.8158 |
| Jul 12, 2024 | 1.8558 | 0.0600 | 3.34% | 1.7958 | 1.8858 | 1.7658 |
| Jul 11, 2024 | 1.8258 | 0.0100 | 0.55% | 1.8158 | 1.8658 | 1.7858 |
| Jul 10, 2024 | 1.7958 | 0.0200 | 1.13% | 1.7758 | 1.7958 | 1.7158 |
| Jul 9, 2024 | 1.7958 | 0.0800 | 4.66% | 1.7158 | 1.8158 | 1.7158 |
| Jul 8, 2024 | 1.7358 | 0.0100 | 0.58% | 1.7258 | 1.7458 | 1.6458 |
| Jul 5, 2024 | 1.6958 | 0.1000 | 6.27% | 1.5958 | 1.6958 | 1.5558 |
| Jul 3, 2024 | 1.6258 | 0.0400 | 2.52% | 1.5858 | 1.6858 | 1.5758 |
| Jul 2, 2024 | 1.6058 | 0.0000 | 0.00% | 1.6058 | 1.7358 | 1.5958 |
| Jul 1, 2024 | 1.6158 | 0.1000 | 6.60% | 1.5158 | 1.6258 | 1.4858 |
| Jun 28, 2024 | 1.5158 | 0.0200 | 1.34% | 1.4958 | 1.5758 | 1.3958 |
| Jun 27, 2024 | 1.4058 | 0.1400 | 11.06% | 1.2658 | 1.4158 | 1.2358 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Ocugen, Inc. Company profile
Ocugen (OCGN) is a biopharmaceutical company focusing on discovering, developing, and commercialising gene therapies to cure blindness illnesses and creating a Covid-19 vaccine.
Founded in 2006, Ocugen became a public company in 2014. The company’s shares are traded on the Nasdaq under the symbol OCGN.
Projects in the pipeline are Covid-19 vaccines, a Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases.
For the Covid-19 vaccine, the company, in collaboration Bharat Biotech, was developing, manufacturing and commercialising COVAXIN for the prevention of the disease for US and Canada markets. COVAXIN is a whole-virion inactivated Covid-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus.
The Modifier Gene Therapy Platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). The technology is licensed from the Schepens Eye Research Institute of Massachusetts Eye and Ear (Harvard Medical School).
The company is developing OCU200, a biologic product candidate for the treatment of severe vision-threatening diseases such as diabetic macular edema (DME), diabetic retinopathy (DR), and wet age-related macular degeneration (Wet-AMD).
Patients affected by these diseases have common symptoms, such as blurry vision and increasing visual loss as the condition develops.
Another technology in the pipeline is OCU400, the company’s first product candidate developed with its Modifier Gene Therapy Platform.
Ocugen is headquartered in Malvern, Pennsylvania.
| Industry: | Biotechnology & Medical Research (NEC) |
11 Great Valley Parkway
MALVERN
PENNSYLVANIA 19355
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com